Explore › Intervention › sertraline)
Intervention

sertraline)

Also known as: Combination treatment (CBT + sertraline up to 200mg/day) for 12 weeks in youth ages 7-17 with separation, social, and/or generalized anxiety disorder AD GAD
3 findings 1 paper 5 related entities View in graph →

Related entities

interventions
Combination treatment (CBT1
conditions
Anxiety Disorders1
outcomes
youth anxiety symptoms1
populations
Adolescents1
studys
PMC64257331

Findings (27)

None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Size: b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)
PMC6425733
Finding details → · Paper → · Graph →

Papers (1)